CEACAM5 and colorectal carcinoma: CEA expression was detected in 35.8% of CRC patients and 3.3% of healthy controls, CK19 was detected in 41.9% of CRC patients and also in 3.3% of the healthy controls, while CK20 was detected in 28.3% of the CRC patients and 6.7% of the controls.